Dihomo-γ-linolenic acid


CAS No. : 1783-84-2

(Synonyms: DGLA; all-cis-8,11,14-Eicosatrienoic acid)

1783-84-2
Price and Availability of CAS No. : 1783-84-2
Size Price Stock
326.28 mM * 500 μL in Ethanol $240 In-stock
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-A0143
M.Wt: 306.48
Formula: C20H34O2
Purity: >98 %
Solubility:
Introduction of 1783-84-2 :

Dihomo-γ-linolenic acid (DGLA) is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid attenuates atherosclerosis in the apolipoprotein E deficient mouse model system[1][2][3]. IC50 & Target:Endogenous Metabolite In Vitro:Dihomo-γ-linolenic acid attenuates pro-inflammatory gene expression in human and mouse macrophages[2].
Dihomo-γ-linolenic acid (50?μM; 24 hours) attenuates IFN-γ induced phosphorylation of STAT1 on serine 727[2].
Dihomo-γ-linolenic acid attenuates IL-1β and TNF-α induced MCP-1 and ICAM-1 expression in human macrophages[2].
Dihomo-γ-linolenic acid attenuates chemokine-driven monocytic migration and macrophage foam cell formation[2].
Dihomo-γ-linolenic acid attenuates the expression of SR-A and CD36 in human macrophages[2].
Dihomo-γ-linolenic acid modulates mitochondrial respiration[2].
Dihomo-γ-linolenic acid modulates the properties of endothelial cells and VSMC[2].
In Vivo:Dihomo-γ-linolenic acid (8?mg/mouse; i.g; twice a week; for 35 days) inhibits growth of xenograft tumors in mice bearing human pancreatic cancer cells (BxPC-3) transfected with delta-5-desaturase shRNA[3].

Your information is safe with us.